pharmaceutical-investing European CHMP Adopts Positive Opinion for Yescarta (axicabtagene ciloleucel)
pharmaceutical-investing Alexion Submits Application for Approval of ALXN1210 as a Treatment for Patients with Paroxysmal Nocturnal Hemoglobinuria in the EU
pharmaceutical-investing Cascadian Therapeutics Gets Pediatric Investigation Plan Waiver for Lead Candidate
